Viewpoint: Challenges and opportunities in tuberculosis research

J Infect Dis. 2012 May 15;205 Suppl 2(Suppl 2):S347-52. doi: 10.1093/infdis/jis190. Epub 2012 Mar 22.
No abstract available

MeSH terms

  • Aging
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / therapeutic use
  • Antitubercular Agents / administration & dosage
  • Antitubercular Agents / therapeutic use
  • Biomarkers
  • Clinical Trials as Topic / methods
  • HIV Infections / complications*
  • HIV Infections / epidemiology*
  • HIV Infections / mortality
  • Humans
  • Mycobacterium tuberculosis
  • Organic Chemicals
  • Pandemics
  • Research / economics
  • Research / trends
  • Research Design*
  • Tuberculosis / complications*
  • Tuberculosis / epidemiology
  • Tuberculosis / mortality
  • Tuberculosis / prevention & control*
  • Tuberculosis Vaccines

Substances

  • Anti-HIV Agents
  • Antitubercular Agents
  • Biomarkers
  • Inmodulen
  • Organic Chemicals
  • Tuberculosis Vaccines